BIMZELX
Live / Registered — Registered (as of 23 Apr 2024)
What this means for you
Registered since 23 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88913764
- Registration number
- 7367364
- Mark type
- Design + words
- Filed
- 13 May 2020
- Published for opposition
- 05 Jan 2021
- Registered
- 23 Apr 2024
- Attorney of record
- Kumiko Ide
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of immunology disorders and diseases, all the aforesaid excluding pharmaceutical preparations and substances acting on the central nervous system
- Class 016 — Paper goods and printed matter: Printed matter, namely, promotional and informational materials in the nature of brochures, pamphlets, newsletters, and stationery relating to pharmaceuticals and the treatment and prevention of immunology disorders and diseases
- Class 044 — Medical, beauty and agricultural services: Health information services, namely, providing information related to the treatment of immunology disorders and diseases; on-line information services, namely, providing information related to the treatment of immunology disorders and diseases
Owner
- UCB Biopharma SRL, Brussels, BE
- UCB Biopharma SRL, Brussels, BE
- UCB Biopharma SRL, 1070 Brussels, BE
Prior registrations
Prosecution history
- 23 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 22 Mar 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Mar 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Feb 2024 — USE AMENDMENT FILED
- 26 Feb 2024 — TEAS STATEMENT OF USE RECEIVED
- 24 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Aug 2023 — SOU EXTENSION 5 GRANTED
- 21 Aug 2023 — SOU EXTENSION 5 FILED
- 23 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 18 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Feb 2023 — SOU EXTENSION 4 GRANTED
- 16 Feb 2023 — SOU EXTENSION 4 FILED